Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors--letter

Cancer Res. 2014 Jan 15;74(2):632; discussion 635. doi: 10.1158/0008-5472.CAN-13-2216. Epub 2014 Jan 9.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Animals
  • CTLA-4 Antigen / immunology*
  • Cancer Vaccines / immunology*
  • Female
  • Neoplasms, Experimental / immunology*
  • Programmed Cell Death 1 Receptor / immunology*
  • T-Lymphocytes / immunology*

Substances

  • CTLA-4 Antigen
  • Cancer Vaccines
  • Programmed Cell Death 1 Receptor